Group 16-20 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what ia biomea fusion

A

clinical stage biopharmaceutical company developing oral covalent small molecule inhibitors to treat cancers and metabolic diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the platform of biomea fusion

A

built their own fusion system platform ro develop treatments against high value oncogenic drivers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is coherus bioscience

A

revenue stage, fully integrated biopharma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the platform of coherus biosciences

A

biosimilar development and immuno-oncology therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is alx oncology

A

clinical stage immuno oncology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the platform of alx oncology

A

next gen cd47 blocking therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is immunity bio inc

A

clinical stage biotech company

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the platform of immunity bioinc

A

usage of combination therapies focusing on the enhancement of the immune system to treat various infectious and oncological diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is omni ab

A

service based biotech company that will partner with pharmaceutical companies to generate thepapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the platform of omni ab

A

Transgenic animal technology to produce human antibodies
* OmniRat, Omnimouse, OmniChicken, OmniTaur, OmniClic, OmniFlic, OmnidAb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is tango therapeutics

A

clinical stage biotech committed to discovering novel drug targets and developing next gen of precision meds for the treatment of cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the platform of tango therapeutics

A

synthetic lethality for targeting specific tumor suppressor gene loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is halozyme therapeutics

A

clinical stage drug delivery platform biopharmaceutical company

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the platform for halozyme therapeutics

A

enhanze drug delivery tech for subcutaneous administration of injected drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is inhibrx

A

single domain antibody (sdAb) platform foundation to build novel drugs that target a variety of cancers (chondrosarcomas, nonsmall cell lung cancer, head/neck cancer) and alpha 1 antitrypsin (AAT) deficiency, which affects the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the platform of inhibrx

A

core sdAb platform is composed of camelid-derived heavy-chain-only antibodies that are miniaturized into sdAbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is indeaya biosciences

A

precision medecine focused, clinical stage biotech focusing on targeted therapied for cancer treatment

18
Q

what is the platform of ideaya therapies

A

Synthetic Lethality (SL), as shown in the figure above, is a drug development strategy that targets specific genetic interactions between two
genes to selectively kill cancer cells by exploiting vulnerabilities created by the loss or mutation of certain genes that occurred exclusively in cancer cells.

19
Q

what is insmed inc biopharma platform

A

integration of early-stage research platforms, gene therapy, RNA End-Joining, protein deimmunization,
synthetic rescue and proprietary manufacturing.

20
Q

what is ironwood

A

leading gastrointestical focused biopharmaceutical company

21
Q

what is structure therapeutics

A

clinical stage global biopharma specializing in orally
available small molecules targeting G-Coupled
Protein Receptors (GPCR

22
Q

what is aclaris therapeutics

A

drug discovery and development kinase inhibitor company

23
Q

what is aclaris platform

A

Kinase inhibition via cystine residues using analysis technology, KINect

24
Q

what is meira gtx

A

clinical stage gene therapy company

25
Q

what is platform of meiragtx

A

use gene therapy to customize many vector elements to design a product candidate specific to the disease being targeted (ocular, neurodegenerative and salivary gland diseases) and that allows
precise control of gene expression using proprietary oral small molecule inducers

26
Q

what is regenxbio

A

clinical stahe biotech comp

27
Q

what is platform of regenxbio

A

NAV® Technology Platform specialized in Adeno-Associated Virus (AVV) Gene Therapy

28
Q

what is vertex pharmaceuticals

A

bostion based biopharma company focused on rational drug design

29
Q

what is the platform of vertex pharma

A

small molecule drugs-expertise in structure-based drug design - development of high target therapies.

30
Q

what is ultragenyx pharmaceutical

A

clinical stage biotech
-Treatments for individuals afflicted with rare and ultra-rare genetic disorders such as X-linked hypophosphatemia (XLH), tumor-induced osteomalacia (TIO), osteogenesis imperfecta and others

31
Q

what is platform of ultragenyx pharmaceutical

A

traditional biologics, small molecules, gene therapies, nucleic acid therapies

32
Q

what is autolus therapeutics

A

develops car t therapies for cancer patients

33
Q

what is platform autolus therapeutics

A

CAR T cell therapy company developing advanced autologous T cell therapies, clinical stage programs for hematological
and solid tumor indications. (Publications: Nature, Molecular Therapy)

34
Q

what is iovance biotherapeutics

A

clinical stage biopharmaceutical company with focus on cancer immunotherapiesw

35
Q

what is the platform of iovance

A

It is mainly based on tumor infiltrating lymphocytes (TIL) therapy that involves isolating T cells from patient’s tumor, expanding them
ex vivo and re-infusing them into the patient to target and kill cancer cells.

36
Q

what is sana biotech

A

Biotechnology company that focuses on engineering cells for hematologic cancers, B-cell
mediated autoimmune diseases, and regenerative medicine

37
Q

what is sana biotech platform

A

engineered CAR T cells, primary islet cells, and iPSCs

38
Q

what is replimune

A

*Clinical-stage biopharmaceutical company focused on advancing a novel pipeline of cancer immunotherapies centered around oncolytic viruses.

39
Q

what is replimune platform

A

Cancer immunotherapies through genetically engineering a proprietary oncolytic virus to enhance tumor specificity and increase therapy safety. Virus then modified with therapeutic transgenes to maximize anti-tumor activity. Designed for unmet cancer needs

40
Q
A